Clinical Trials List
2025-12-08 - 2032-09-03
Phase III
Recruiting5
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃怡菁 無
- 魏慈慧 無
- Kuo-Ting Lee 無
- 楊舜如 無
- Shang-Hung Chen 無
- Zhu-Jun Loh 無
- Chun-Hui Lee 無
- Jui-Hung Tsai 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chun-Yu Liu 無
- 林燕淑 無
- Chi-Cheng Huang 無
- Jiun-I Lai 無
- 陳彥蓁 無
- Yi-Fang Tsai 無
- Ta-Chung Chao 無
- 賴亦貞 無
- 鄭涵方 無
- 邱仁輝 無
- 馮晉榮 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 楊捷儒 無
- 王國鐘 無
- ZHENG-WEI ZHOU 無
- Huey-En Tzeng 無
- 劉佳樺 無
- Kuan-Der Lee 無
- 楊陽生 無
- 林慈恩 無
- I-Chen Tsai 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30-65 participants
-
Global
920 participants
